1 Report Business Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Malignant Melanoma Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Surgical Therapy 1.2.3 Radiation Therapy 1.2.4 Chemotherapy 1.2.5 Biological Therapy/Targeted Therapy 1.3 Market by Application 1.3.1 Global Malignant Melanoma Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Hospitals 1.3.3 Clinics 1.3.4 Ambulatory Surgical Centers 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Malignant Melanoma Treatment Market Perspective (2017-2028) 2.2 Malignant Melanoma Treatment Growth Trends by Region 2.2.1 Malignant Melanoma Treatment Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Malignant Melanoma Treatment Historic Market Size by Region (2017-2022) 2.2.3 Malignant Melanoma Treatment Forecasted Market Size by Region (2023-2028) 2.3 Malignant Melanoma Treatment Market Dynamics 2.3.1 Malignant Melanoma Treatment Industry Trends 2.3.2 Malignant Melanoma Treatment Market Drivers 2.3.3 Malignant Melanoma Treatment Market Challenges 2.3.4 Malignant Melanoma Treatment Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Malignant Melanoma Treatment Players by Revenue 3.1.1 Global Top Malignant Melanoma Treatment Players by Revenue (2017-2022) 3.1.2 Global Malignant Melanoma Treatment Revenue Market Share by Players (2017-2022) 3.2 Global Malignant Melanoma Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Malignant Melanoma Treatment Revenue 3.4 Global Malignant Melanoma Treatment Market Concentration Ratio 3.4.1 Global Malignant Melanoma Treatment Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Malignant Melanoma Treatment Revenue in 2021 3.5 Malignant Melanoma Treatment Key Players Head office and Area Served 3.6 Key Players Malignant Melanoma Treatment Product Solution and Service 3.7 Date of Enter into Malignant Melanoma Treatment Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Malignant Melanoma Treatment Breakdown Data by Type 4.1 Global Malignant Melanoma Treatment Historic Market Size by Type (2017-2022) 4.2 Global Malignant Melanoma Treatment Forecasted Market Size by Type (2023-2028) 5 Malignant Melanoma Treatment Breakdown Data by Application 5.1 Global Malignant Melanoma Treatment Historic Market Size by Application (2017-2022) 5.2 Global Malignant Melanoma Treatment Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Malignant Melanoma Treatment Market Size (2017-2028) 6.2 North America Malignant Melanoma Treatment Market Size by Type 6.2.1 North America Malignant Melanoma Treatment Market Size by Type (2017-2022) 6.2.2 North America Malignant Melanoma Treatment Market Size by Type (2023-2028) 6.2.3 North America Malignant Melanoma Treatment Market Share by Type (2017-2028) 6.3 North America Malignant Melanoma Treatment Market Size by Application 6.3.1 North America Malignant Melanoma Treatment Market Size by Application (2017-2022) 6.3.2 North America Malignant Melanoma Treatment Market Size by Application (2023-2028) 6.3.3 North America Malignant Melanoma Treatment Market Share by Application (2017-2028) 6.4 North America Malignant Melanoma Treatment Market Size by Country 6.4.1 North America Malignant Melanoma Treatment Market Size by Country (2017-2022) 6.4.2 North America Malignant Melanoma Treatment Market Size by Country (2023-2028) 6.4.3 U.S. 6.4.4 Canada 7 Europe 7.1 Europe Malignant Melanoma Treatment Market Size (2017-2028) 7.2 Europe Malignant Melanoma Treatment Market Size by Type 7.2.1 Europe Malignant Melanoma Treatment Market Size by Type (2017-2022) 7.2.2 Europe Malignant Melanoma Treatment Market Size by Type (2023-2028) 7.2.3 Europe Malignant Melanoma Treatment Market Share by Type (2017-2028) 7.3 Europe Malignant Melanoma Treatment Market Size by Application 7.3.1 Europe Malignant Melanoma Treatment Market Size by Application (2017-2022) 7.3.2 Europe Malignant Melanoma Treatment Market Size by Application (2023-2028) 7.3.3 Europe Malignant Melanoma Treatment Market Share by Application (2017-2028) 7.4 Europe Malignant Melanoma Treatment Market Size by Country 7.4.1 Europe Malignant Melanoma Treatment Market Size by Country (2017-2022) 7.4.2 Europe Malignant Melanoma Treatment Market Size by Country (2023-2028) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Malignant Melanoma Treatment Market Size (2017-2028) 8.2 Asia-Pacific Malignant Melanoma Treatment Market Size by Type 8.2.1 Asia-Pacific Malignant Melanoma Treatment Market Size by Type (2017-2022) 8.2.2 Asia-Pacific Malignant Melanoma Treatment Market Size by Type (2023-2028) 8.2.3 Asia-Pacific Malignant Melanoma Treatment Market Share by Type (2017-2028) 8.3 Asia-Pacific Malignant Melanoma Treatment Market Size by Application 8.3.1 Asia-Pacific Malignant Melanoma Treatment Market Size by Application (2017-2022) 8.3.2 Asia-Pacific Malignant Melanoma Treatment Market Size by Application (2023-2028) 8.3.3 Asia-Pacific Malignant Melanoma Treatment Market Share by Application (2017-2028) 8.4 Asia-Pacific Malignant Melanoma Treatment Market Size by Region 8.4.1 Asia-Pacific Malignant Melanoma Treatment Market Size by Region (2017-2022) 8.4.2 Asia-Pacific Malignant Melanoma Treatment Market Size by Region (2023-2028) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Malignant Melanoma Treatment Market Size (2017-2028) 9.2 Latin America Malignant Melanoma Treatment Market Size by Type 9.2.1 Latin America Malignant Melanoma Treatment Market Size by Type (2017-2022) 9.2.2 Latin America Malignant Melanoma Treatment Market Size by Type (2023-2028) 9.2.3 Latin America Malignant Melanoma Treatment Market Share by Type (2017-2028) 9.3 Latin America Malignant Melanoma Treatment Market Size by Application 9.3.1 Latin America Malignant Melanoma Treatment Market Size by Application (2017-2022) 9.3.2 Latin America Malignant Melanoma Treatment Market Size by Application (2023-2028) 9.3.3 Latin America Malignant Melanoma Treatment Market Share by Application (2017-2028) 9.4 Latin America Malignant Melanoma Treatment Market Size by Country 9.4.1 Latin America Malignant Melanoma Treatment Market Size by Country (2017-2022) 9.4.2 Latin America Malignant Melanoma Treatment Market Size by Country (2023-2028) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Malignant Melanoma Treatment Market Size (2017-2028) 10.2 Middle East & Africa Malignant Melanoma Treatment Market Size by Type 10.2.1 Middle East & Africa Malignant Melanoma Treatment Market Size by Type (2017-2022) 10.2.2 Middle East & Africa Malignant Melanoma Treatment Market Size by Type (2023-2028) 10.2.3 Middle East & Africa Malignant Melanoma Treatment Market Share by Type (2017-2028) 10.3 Middle East & Africa Malignant Melanoma Treatment Market Size by Application 10.3.1 Middle East & Africa Malignant Melanoma Treatment Market Size by Application (2017-2022) 10.3.2 Middle East & Africa Malignant Melanoma Treatment Market Size by Application (2023-2028) 10.3.3 Middle East & Africa Malignant Melanoma Treatment Market Share by Application (2017-2028) 10.4 Middle East & Africa Malignant Melanoma Treatment Market Size by Country 10.4.1 Middle East & Africa Malignant Melanoma Treatment Market Size by Country (2017-2022) 10.4.2 Middle East & Africa Malignant Melanoma Treatment Market Size by Country (2023-2028) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Bristol-Myers Squibb 11.1.1 Bristol-Myers Squibb Company Details 11.1.2 Bristol-Myers Squibb Business Overview 11.1.3 Bristol-Myers Squibb Malignant Melanoma Treatment Introduction 11.1.4 Bristol-Myers Squibb Revenue in Malignant Melanoma Treatment Business (2017-2022) 11.1.5 Bristol-Myers Squibb Recent Developments 11.2 Enzon Pharmaceuticals 11.2.1 Enzon Pharmaceuticals Company Details 11.2.2 Enzon Pharmaceuticals Business Overview 11.2.3 Enzon Pharmaceuticals Malignant Melanoma Treatment Introduction 11.2.4 Enzon Pharmaceuticals Revenue in Malignant Melanoma Treatment Business (2017-2022) 11.2.5 Enzon Pharmaceuticals Recent Developments 11.3 Exelixis 11.3.1 Exelixis Company Details 11.3.2 Exelixis Business Overview 11.3.3 Exelixis Malignant Melanoma Treatment Introduction 11.3.4 Exelixis Revenue in Malignant Melanoma Treatment Business (2017-2022) 11.3.5 Exelixis Recent Developments 11.4 GSK 11.4.1 GSK Company Details 11.4.2 GSK Business Overview 11.4.3 GSK Malignant Melanoma Treatment Introduction 11.4.4 GSK Revenue in Malignant Melanoma Treatment Business (2017-2022) 11.4.5 GSK Recent Developments 11.5 Merck 11.5.1 Merck Company Details 11.5.2 Merck Business Overview 11.5.3 Merck Malignant Melanoma Treatment Introduction 11.5.4 Merck Revenue in Malignant Melanoma Treatment Business (2017-2022) 11.5.5 Merck Recent Developments 11.6 Pfizer 11.6.1 Pfizer Company Details 11.6.2 Pfizer Business Overview 11.6.3 Pfizer Malignant Melanoma Treatment Introduction 11.6.4 Pfizer Revenue in Malignant Melanoma Treatment Business (2017-2022) 11.6.5 Pfizer Recent Developments 11.7 Roche 11.7.1 Roche Company Details 11.7.2 Roche Business Overview 11.7.3 Roche Malignant Melanoma Treatment Introduction 11.7.4 Roche Revenue in Malignant Melanoma Treatment Business (2017-2022) 11.7.5 Roche Recent Developments 11.8 Navidea Biopharmaceuticals 11.8.1 Navidea Biopharmaceuticals Company Details 11.8.2 Navidea Biopharmaceuticals Business Overview 11.8.3 Navidea Biopharmaceuticals Malignant Melanoma Treatment Introduction 11.8.4 Navidea Biopharmaceuticals Revenue in Malignant Melanoma Treatment Business (2017-2022) 11.8.5 Navidea Biopharmaceuticals Recent Developments 11.9 Novartis 11.9.1 Novartis Company Details 11.9.2 Novartis Business Overview 11.9.3 Novartis Malignant Melanoma Treatment Introduction 11.9.4 Novartis Revenue in Malignant Melanoma Treatment Business (2017-2022) 11.9.5 Novartis Recent Developments 11.10 Ono Pharmaceutical 11.10.1 Ono Pharmaceutical Company Details 11.10.2 Ono Pharmaceutical Business Overview 11.10.3 Ono Pharmaceutical Malignant Melanoma Treatment Introduction 11.10.4 Ono Pharmaceutical Revenue in Malignant Melanoma Treatment Business (2017-2022) 11.10.5 Ono Pharmaceutical Recent Developments 11.11 Amgen 11.11.1 Amgen Company Details 11.11.2 Amgen Business Overview 11.11.3 Amgen Malignant Melanoma Treatment Introduction 11.11.4 Amgen Revenue in Malignant Melanoma Treatment Business (2017-2022) 11.11.5 Amgen Recent Developments 11.12 Avax Technologies 11.12.1 Avax Technologies Company Details 11.12.2 Avax Technologies Business Overview 11.12.3 Avax Technologies Malignant Melanoma Treatment Introduction 11.12.4 Avax Technologies Revenue in Malignant Melanoma Treatment Business (2017-2022) 11.12.5 Avax Technologies Recent Developments 11.13 Clinigen Group 11.13.1 Clinigen Group Company Details 11.13.2 Clinigen Group Business Overview 11.13.3 Clinigen Group Malignant Melanoma Treatment Introduction 11.13.4 Clinigen Group Revenue in Malignant Melanoma Treatment Business (2017-2022) 11.13.5 Clinigen Group Recent Developments 11.14 Pierre Fabre Group 11.14.1 Pierre Fabre Group Company Details 11.14.2 Pierre Fabre Group Business Overview 11.14.3 Pierre Fabre Group Malignant Melanoma Treatment Introduction 11.14.4 Pierre Fabre Group Revenue in Malignant Melanoma Treatment Business (2017-2022) 11.14.5 Pierre Fabre Group Recent Developments 11.15 Aptose Biosciences 11.15.1 Aptose Biosciences Company Details 11.15.2 Aptose Biosciences Business Overview 11.15.3 Aptose Biosciences Malignant Melanoma Treatment Introduction 11.15.4 Aptose Biosciences Revenue in Malignant Melanoma Treatment Business (2017-2022) 11.15.5 Aptose Biosciences Recent Developments 11.16 Daiichi Sankyo 11.16.1 Daiichi Sankyo Company Details 11.16.2 Daiichi Sankyo Business Overview 11.16.3 Daiichi Sankyo Malignant Melanoma Treatment Introduction 11.16.4 Daiichi Sankyo Revenue in Malignant Melanoma Treatment Business (2017-2022) 11.16.5 Daiichi Sankyo Recent Developments 11.17 Sanofi 11.17.1 Sanofi Company Details 11.17.2 Sanofi Business Overview 11.17.3 Sanofi Malignant Melanoma Treatment Introduction 11.17.4 Sanofi Revenue in Malignant Melanoma Treatment Business (2017-2022) 11.17.5 Sanofi Recent Developments 11.18 Takeda Pharmaceutical 11.18.1 Takeda Pharmaceutical Company Details 11.18.2 Takeda Pharmaceutical Business Overview 11.18.3 Takeda Pharmaceutical Malignant Melanoma Treatment Introduction 11.18.4 Takeda Pharmaceutical Revenue in Malignant Melanoma Treatment Business (2017-2022) 11.18.5 Takeda Pharmaceutical Recent Developments 11.19 Qiagen 11.19.1 Qiagen Company Details 11.19.2 Qiagen Business Overview 11.19.3 Qiagen Malignant Melanoma Treatment Introduction 11.19.4 Qiagen Revenue in Malignant Melanoma Treatment Business (2017-2022) 11.19.5 Qiagen Recent Developments 11.20 AstraZeneca 11.20.1 AstraZeneca Company Details 11.20.2 AstraZeneca Business Overview 11.20.3 AstraZeneca Malignant Melanoma Treatment Introduction 11.20.4 AstraZeneca Revenue in Malignant Melanoma Treatment Business (2017-2022) 11.20.5 AstraZeneca Recent Developments 11.21 Biogen 11.21.1 Biogen Company Details 11.21.2 Biogen Business Overview 11.21.3 Biogen Malignant Melanoma Treatment Introduction 11.21.4 Biogen Revenue in Malignant Melanoma Treatment Business (2017-2022) 11.21.5 Biogen Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Author Details 13.3 Disclaimer

List of Tables Table 1. Global Malignant Melanoma Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028 Table 2. Key Players of Surgical Therapy Table 3. Key Players of Radiation Therapy Table 4. Key Players of Chemotherapy Table 5. Key Players of Biological Therapy/Targeted Therapy Table 6. Global Malignant Melanoma Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028 Table 7. Global Malignant Melanoma Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 8. Global Malignant Melanoma Treatment Market Size by Region (2017-2022) & (US$ Million) Table 9. Global Malignant Melanoma Treatment Market Share by Region (2017-2022) Table 10. Global Malignant Melanoma Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 11. Global Malignant Melanoma Treatment Market Share by Region (2023-2028) Table 12. Malignant Melanoma Treatment Market Trends Table 13. Malignant Melanoma Treatment Market Drivers Table 14. Malignant Melanoma Treatment Market Challenges Table 15. Malignant Melanoma Treatment Market Restraints Table 16. Global Malignant Melanoma Treatment Revenue by Players (2017-2022) & (US$ Million) Table 17. Global Malignant Melanoma Treatment Revenue Share by Players (2017-2022) Table 18. Global Top Malignant Melanoma Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Malignant Melanoma Treatment as of 2021) Table 19. Ranking of Global Top Malignant Melanoma Treatment Companies by Revenue (US$ Million) in 2021 Table 20. Global 5 Largest Players Market Share by Malignant Melanoma Treatment Revenue (CR5 and HHI) & (2017-2022) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Malignant Melanoma Treatment Product Solution and Service Table 23. Date of Enter into Malignant Melanoma Treatment Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Malignant Melanoma Treatment Market Size by Type (2017-2022) & (US$ Million) Table 26. Global Malignant Melanoma Treatment Revenue Market Share by Type (2017-2022) Table 27. Global Malignant Melanoma Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 28. Global Malignant Melanoma Treatment Revenue Market Share by Type (2023-2028) Table 29. Global Malignant Melanoma Treatment Market Size by Application (2017-2022) & (US$ Million) Table 30. Global Malignant Melanoma Treatment Revenue Share by Application (2017-2022) Table 31. Global Malignant Melanoma Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 32. Global Malignant Melanoma Treatment Revenue Share by Application (2023-2028) Table 33. North America Malignant Melanoma Treatment Market Size by Type (2017-2022) & (US$ Million) Table 34. North America Malignant Melanoma Treatment Market Size by Type (2023-2028) & (US$ Million) Table 35. North America Malignant Melanoma Treatment Market Size by Application (2017-2022) & (US$ Million) Table 36. North America Malignant Melanoma Treatment Market Size by Application (2023-2028) & (US$ Million) Table 37. North America Malignant Melanoma Treatment Market Size by Country (2017-2022) & (US$ Million) Table 38. North America Malignant Melanoma Treatment Market Size by Country (2023-2028) & (US$ Million) Table 39. Europe Malignant Melanoma Treatment Market Size by Type (2017-2022) & (US$ Million) Table 40. Europe Malignant Melanoma Treatment Market Size by Type (2023-2028) & (US$ Million) Table 41. Europe Malignant Melanoma Treatment Market Size by Application (2017-2022) & (US$ Million) Table 42. Europe Malignant Melanoma Treatment Market Size by Application (2023-2028) & (US$ Million) Table 43. Europe Malignant Melanoma Treatment Market Size by Country (2017-2022) & (US$ Million) Table 44. Europe Malignant Melanoma Treatment Market Size by Country (2023-2028) & (US$ Million) Table 45. Asia Pacific Malignant Melanoma Treatment Market Size by Type (2017-2022) & (US$ Million) Table 46. Asia Pacific Malignant Melanoma Treatment Market Size by Type (2023-2028) & (US$ Million) Table 47. Asia Pacific Malignant Melanoma Treatment Market Size by Application (2017-2022) & (US$ Million) Table 48. Asia Pacific Malignant Melanoma Treatment Market Size by Application (2023-2028) & (US$ Million) Table 49. Asia Pacific Malignant Melanoma Treatment Market Size by Region (2017-2022) & (US$ Million) Table 50. Asia Pacific Malignant Melanoma Treatment Market Size by Region (2023-2028) & (US$ Million) Table 51. Latin America Malignant Melanoma Treatment Market Size by Type (2017-2022) & (US$ Million) Table 52. Latin America Malignant Melanoma Treatment Market Size by Type (2023-2028) & (US$ Million) Table 53. Latin America Malignant Melanoma Treatment Market Size by Application (2017-2022) & (US$ Million) Table 54. Latin America Malignant Melanoma Treatment Market Size by Application (2023-2028) & (US$ Million) Table 55. Latin America Malignant Melanoma Treatment Market Size by Country (2017-2022) & (US$ Million) Table 56. Latin America Malignant Melanoma Treatment Market Size by Country (2023-2028) & (US$ Million) Table 57. Middle East and Africa Malignant Melanoma Treatment Market Size by Type (2017-2022) & (US$ Million) Table 58. Middle East and Africa Malignant Melanoma Treatment Market Size by Type (2023-2028) & (US$ Million) Table 59. Middle East and Africa Malignant Melanoma Treatment Market Size by Application (2017-2022) & (US$ Million) Table 60. Middle East and Africa Malignant Melanoma Treatment Market Size by Application (2023-2028) & (US$ Million) Table 61. Middle East and Africa Malignant Melanoma Treatment Market Size by Country (2017-2022) & (US$ Million) Table 62. Middle East and Africa Malignant Melanoma Treatment Market Size by Country (2023-2028) & (US$ Million) Table 63. Bristol-Myers Squibb Company Details Table 64. Bristol-Myers Squibb Business Overview Table 65. Bristol-Myers Squibb Malignant Melanoma Treatment Product Table 66. Bristol-Myers Squibb Revenue in Malignant Melanoma Treatment Business (2017-2022) & (US$ Million) Table 67. Bristol-Myers Squibb Recent Developments Table 68. Enzon Pharmaceuticals Company Details Table 69. Enzon Pharmaceuticals Business Overview Table 70. Enzon Pharmaceuticals Malignant Melanoma Treatment Product Table 71. Enzon Pharmaceuticals Revenue in Malignant Melanoma Treatment Business (2017-2022) & (US$ Million) Table 72. Enzon Pharmaceuticals Recent Developments Table 73. Exelixis Company Details Table 74. Exelixis Business Overview Table 75. Exelixis Malignant Melanoma Treatment Product Table 76. Exelixis Revenue in Malignant Melanoma Treatment Business (2017-2022) & (US$ Million) Table 77. Exelixis Recent Developments Table 78. GSK Company Details Table 79. GSK Business Overview Table 80. GSK Malignant Melanoma Treatment Product Table 81. GSK Revenue in Malignant Melanoma Treatment Business (2017-2022) & (US$ Million) Table 82. GSK Recent Developments Table 83. Merck Company Details Table 84. Merck Business Overview Table 85. Merck Malignant Melanoma Treatment Product Table 86. Merck Revenue in Malignant Melanoma Treatment Business (2017-2022) & (US$ Million) Table 87. Merck Recent Developments Table 88. Pfizer Company Details Table 89. Pfizer Business Overview Table 90. Pfizer Malignant Melanoma Treatment Product Table 91. Pfizer Revenue in Malignant Melanoma Treatment Business (2017-2022) & (US$ Million) Table 92. Pfizer Recent Developments Table 93. Roche Company Details Table 94. Roche Business Overview Table 95. Roche Malignant Melanoma Treatment Product Table 96. Roche Revenue in Malignant Melanoma Treatment Business (2017-2022) & (US$ Million) Table 97. Roche Recent Developments Table 98. Navidea Biopharmaceuticals Company Details Table 99. Navidea Biopharmaceuticals Business Overview Table 100. Navidea Biopharmaceuticals Malignant Melanoma Treatment Product Table 101. Navidea Biopharmaceuticals Revenue in Malignant Melanoma Treatment Business (2017-2022) & (US$ Million) Table 102. Navidea Biopharmaceuticals Recent Developments Table 103. Novartis Company Details Table 104. Novartis Business Overview Table 105. Novartis Malignant Melanoma Treatment Product Table 106. Novartis Revenue in Malignant Melanoma Treatment Business (2017-2022) & (US$ Million) Table 107. Novartis Recent Developments Table 108. Ono Pharmaceutical Company Details Table 109. Ono Pharmaceutical Business Overview Table 110. Ono Pharmaceutical Malignant Melanoma Treatment Product Table 111. Ono Pharmaceutical Revenue in Malignant Melanoma Treatment Business (2017-2022) & (US$ Million) Table 112. Ono Pharmaceutical Recent Developments Table 113. Amgen Company Details Table 114. Amgen Business Overview Table 115. Amgen Malignant Melanoma Treatment Product Table 116. Amgen Revenue in Malignant Melanoma Treatment Business (2017-2022) & (US$ Million) Table 117. Amgen Recent Developments Table 118. Avax Technologies Company Details Table 119. Avax Technologies Business Overview Table 120. Avax Technologies Malignant Melanoma Treatment Product Table 121. Avax Technologies Revenue in Malignant Melanoma Treatment Business (2017-2022) & (US$ Million) Table 122. Avax Technologies Recent Developments Table 123. Clinigen Group Company Details Table 124. Clinigen Group Business Overview Table 125. Clinigen Group Malignant Melanoma Treatment Product Table 126. Clinigen Group Revenue in Malignant Melanoma Treatment Business (2017-2022) & (US$ Million) Table 127. Clinigen Group Recent Developments Table 128. Pierre Fabre Group Company Details Table 129. Pierre Fabre Group Business Overview Table 130. Pierre Fabre Group Malignant Melanoma Treatment Product Table 131. Pierre Fabre Group Revenue in Malignant Melanoma Treatment Business (2017-2022) & (US$ Million) Table 132. Pierre Fabre Group Recent Developments Table 133. Aptose Biosciences Company Details Table 134. Aptose Biosciences Business Overview Table 135. Aptose Biosciences Malignant Melanoma Treatment Product Table 136. Aptose Biosciences Revenue in Malignant Melanoma Treatment Business (2017-2022) & (US$ Million) Table 137. Aptose Biosciences Recent Developments Table 138. Daiichi Sankyo Company Details Table 139. Daiichi Sankyo Business Overview Table 140. Daiichi Sankyo Malignant Melanoma Treatment Product Table 141. Daiichi Sankyo Revenue in Malignant Melanoma Treatment Business (2017-2022) & (US$ Million) Table 142. Daiichi Sankyo Recent Developments Table 143. Sanofi Company Details Table 144. Sanofi Business Overview Table 145. Sanofi Malignant Melanoma Treatment Product Table 146. Sanofi Revenue in Malignant Melanoma Treatment Business (2017-2022) & (US$ Million) Table 147. Sanofi Recent Developments Table 148. Takeda Pharmaceutical Company Details Table 149. Takeda Pharmaceutical Business Overview Table 150. Takeda Pharmaceutical Malignant Melanoma Treatment Product Table 151. Takeda Pharmaceutical Revenue in Malignant Melanoma Treatment Business (2017-2022) & (US$ Million) Table 152. Takeda Pharmaceutical Recent Developments Table 153. Qiagen Company Details Table 154. Qiagen Business Overview Table 155. Qiagen Malignant Melanoma Treatment Product Table 156. Qiagen Revenue in Malignant Melanoma Treatment Business (2017-2022) & (US$ Million) Table 157. Qiagen Recent Developments Table 158. AstraZeneca Company Details Table 159. AstraZeneca Business Overview Table 160. AstraZeneca Malignant Melanoma Treatment Product Table 161. AstraZeneca Revenue in Malignant Melanoma Treatment Business (2017-2022) & (US$ Million) Table 162. AstraZeneca Recent Developments Table 163. Biogen Company Details Table 164. Biogen Business Overview Table 165. Biogen Malignant Melanoma Treatment Product Table 166. Biogen Revenue in Malignant Melanoma Treatment Business (2017-2022) & (US$ Million) Table 167. Biogen Recent Developments Table 168. Research Programs/Design for This Report Table 169. Key Data Information from Secondary Sources Table 170. Key Data Information from Primary Sources List of Figures Figure 1. Global Malignant Melanoma Treatment Market Share by Type: 2021 VS 2028 Figure 2. Surgical Therapy Features Figure 3. Radiation Therapy Features Figure 4. Chemotherapy Features Figure 5. Biological Therapy/Targeted Therapy Features Figure 6. Global Malignant Melanoma Treatment Market Share by Application: 2021 VS 2028 Figure 7. Hospitals Case Studies Figure 8. Clinics Case Studies Figure 9. Ambulatory Surgical Centers Case Studies Figure 10. Others Case Studies Figure 11. Malignant Melanoma Treatment Report Years Considered Figure 12. Global Malignant Melanoma Treatment Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 13. Global Malignant Melanoma Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 14. Global Malignant Melanoma Treatment Market Share by Region: 2021 VS 2028 Figure 15. Global Malignant Melanoma Treatment Market Share by Players in 2021 Figure 16. Global Top Malignant Melanoma Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Malignant Melanoma Treatment as of 2021) Figure 17. The Top 10 and 5 Players Market Share by Malignant Melanoma Treatment Revenue in 2021 Figure 18. North America Malignant Melanoma Treatment Market Size YoY (2017-2028) & (US$ Million) Figure 19. North America Malignant Melanoma Treatment Market Size Market Share by Type (2017-2028) Figure 20. North America Malignant Melanoma Treatment Market Size Market Share by Application (2017-2028) Figure 21. North America Malignant Melanoma Treatment Market Size Share by Country (2017-2028) Figure 22. United States Malignant Melanoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. Canada Malignant Melanoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 24. Europe Malignant Melanoma Treatment Market Size YoY (2017-2028) & (US$ Million) Figure 25. Europe Malignant Melanoma Treatment Market Size Market Share by Type (2017-2028) Figure 26. Europe Malignant Melanoma Treatment Market Size Market Share by Application (2017-2028) Figure 27. Europe Malignant Melanoma Treatment Market Size Share by Country (2017-2028) Figure 28. Germany Malignant Melanoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. France Malignant Melanoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. U.K. Malignant Melanoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. Italy Malignant Melanoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. Russia Malignant Melanoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. Nordic Countries Malignant Melanoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. Asia-Pacific Malignant Melanoma Treatment Market Size YoY (2017-2028) & (US$ Million) Figure 35. Asia Pacific Malignant Melanoma Treatment Market Size Market Share by Type (2017-2028) Figure 36. Asia Pacific Malignant Melanoma Treatment Market Size Market Share by Application (2017-2028) Figure 37. Asia Pacific Malignant Melanoma Treatment Market Size Share by Region (2017-2028) Figure 38. China Malignant Melanoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Japan Malignant Melanoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. South Korea Malignant Melanoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. Southeast Asia Malignant Melanoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. India Malignant Melanoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. Australia Malignant Melanoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million) List of Figures Figure 44. Latin America Malignant Melanoma Treatment Market Size YoY (2017-2028) & (US$ Million) Figure 45. Latin America Malignant Melanoma Treatment Market Size Market Share by Type (2017-2028) Figure 46. Latin America Malignant Melanoma Treatment Market Size Market Share by Application (2017-2028) Figure 47. Latin America Malignant Melanoma Treatment Market Size Share by Country (2017-2028) Figure 48. Mexico Malignant Melanoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 49. Brazil Malignant Melanoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 50. Middle East & Africa Malignant Melanoma Treatment Market Size YoY (2017-2028) & (US$ Million) Figure 51. Middle East and Africa Malignant Melanoma Treatment Market Size Market Share by Type (2017-2028) Figure 52. Middle East and Africa Malignant Melanoma Treatment Market Size Market Share by Application (2017-2028) Figure 53. Middle East and Africa Malignant Melanoma Treatment Market Size Share by Country (2017-2028) Figure 54. Turkey Malignant Melanoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 55. Saudi Arabia Malignant Melanoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 56. UAE Malignant Melanoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 57. Bristol-Myers Squibb Revenue Growth Rate in Malignant Melanoma Treatment Business (2017-2022) Figure 58. Enzon Pharmaceuticals Revenue Growth Rate in Malignant Melanoma Treatment Business (2017-2022) Figure 59. Exelixis Revenue Growth Rate in Malignant Melanoma Treatment Business (2017-2022) Figure 60. GSK Revenue Growth Rate in Malignant Melanoma Treatment Business (2017-2022) Figure 61. Merck Revenue Growth Rate in Malignant Melanoma Treatment Business (2017-2022) Figure 62. Pfizer Revenue Growth Rate in Malignant Melanoma Treatment Business (2017-2022) Figure 63. Roche Revenue Growth Rate in Malignant Melanoma Treatment Business (2017-2022) Figure 64. Navidea Biopharmaceuticals Revenue Growth Rate in Malignant Melanoma Treatment Business (2017-2022) Figure 65. Novartis Revenue Growth Rate in Malignant Melanoma Treatment Business (2017-2022) Figure 66. Ono Pharmaceutical Revenue Growth Rate in Malignant Melanoma Treatment Business (2017-2022) Figure 67. Amgen Revenue Growth Rate in Malignant Melanoma Treatment Business (2017-2022) Figure 68. Avax Technologies Revenue Growth Rate in Malignant Melanoma Treatment Business (2017-2022) Figure 69. Clinigen Group Revenue Growth Rate in Malignant Melanoma Treatment Business (2017-2022) Figure 70. Pierre Fabre Group Revenue Growth Rate in Malignant Melanoma Treatment Business (2017-2022) Figure 71. Aptose Biosciences Revenue Growth Rate in Malignant Melanoma Treatment Business (2017-2022) Figure 72. Daiichi Sankyo Revenue Growth Rate in Malignant Melanoma Treatment Business (2017-2022) Figure 73. Sanofi Revenue Growth Rate in Malignant Melanoma Treatment Business (2017-2022) Figure 74. Takeda Pharmaceutical Revenue Growth Rate in Malignant Melanoma Treatment Business (2017-2022) Figure 75. Qiagen Revenue Growth Rate in Malignant Melanoma Treatment Business (2017-2022) Figure 76. AstraZeneca Revenue Growth Rate in Malignant Melanoma Treatment Business (2017-2022) Figure 77. Biogen Revenue Growth Rate in Malignant Melanoma Treatment Business (2017-2022) Figure 78. Bottom-up and Top-down Approaches for This Report Figure 79. Data Triangulation Figure 80. Key Executives Interviewed

Bristol-Myers Squibb Enzon Pharmaceuticals Exelixis GSK Merck Pfizer Roche Navidea Biopharmaceuticals Novartis Ono Pharmaceutical Amgen Avax Technologies Clinigen Group Pierre Fabre Group Aptose Biosciences Daiichi Sankyo Sanofi Takeda Pharmaceutical Qiagen AstraZeneca Biogen